Propofol Versus the Use of Dexmedetomidine as a Sedative Agent for Colonosopy

• Status: Unknown status
• Trial end date: 2020-04-01
• Target enrollment: 0
• Participant gender: All

Summary

Dexmedetomidine as a Sedative Agent for Patients Presented for Lower Gastrointestinal Endoscopy

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tanta University
• Treatments: Dexmedetomidine; Hypnotics and Sedatives; Propofol

Criteria

Inclusion Criteria:

• aged 25-45 years,

• ASA class I or II,

• who are scheduled for elective outpatient colonoscopy

Exclusion Criteria:

• refused to give informed consent

• if they had known hypersensitivity to the used drugs

• patients with morbidly obese patients

• patients with increased risk for airway obstruction as obstructive sleep apnea,

• Liver diseases